 So in original. Probably should be preceded by “laboratory”.

(as defined in subsection (d)(5)) under subsection (d).

Editorial Notes

Amendments

2024—Subsec. (a)(1)(B)(i). Pub. L. 118–83, § 221(b)(1), substituted “2025” for “2024”.

Subsec. (a)(1)(B)(ii). Pub. L. 118–83, § 221(b)(2), substituted “2026” for “2025” in two places.

Subsec. (b)(3)(A). Pub. L. 118–83, § 221(a)(1), substituted “2028” for “2027”.

Subsec. (b)(3)(B)(ii). Pub. L. 118–83, § 221(a)(2)(A), substituted “2025” for “2024”.

Subsec. (b)(3)(B)(iii). Pub. L. 118–83, § 221(a)(2)(B), substituted “2026 through 2028” for “2025 through 2027”.

2023—Subsec. (a)(1)(B)(i). Pub. L. 118–22, § 502(b)(1), substituted “2024” for “2023”.

Subsec. (a)(1)(B)(ii). Pub. L. 118–22, § 502(b)(2), substituted “2025” for “2024” in two places.

Subsec. (b)(3)(A). Pub. L. 118–22, § 502(a)(1), substituted “2027” for “2026”.

Subsec. (b)(3)(B)(ii). Pub. L. 118–22, § 502(a)(2)(A), substituted “2024” for “2023”.

Subsec. (b)(3)(B)(iii). Pub. L. 118–22, § 502(a)(2)(B), substituted “2025 through 2027” for “2024 through 2026”.

2022—Subsec. (a)(1)(B)(i). Pub. L. 117–328, § 4114(b)(1), substituted “December 31, 2023” for “December 31, 2022”.

Subsec. (a)(1)(B)(ii). Pub. L. 117–328, § 4114(b)(2), substituted “January 1, 2024” for “January 1, 2023” and “March 31, 2024” for “March 31, 2023”.

Subsec. (b)(3)(A). Pub. L. 117–328, § 4114(a)(1), substituted “through 2026” for “through 2025”.

Subsec. (b)(3)(B)(ii). Pub. L. 117–328, § 4114(a)(2)(A), substituted “through 2023” for “and 2022”.

Subsec. (b)(3)(B)(iii). Pub. L. 117–328, § 4114(a)(2)(B), substituted “2024 through 2026” for “2023 through 2025”.

Subsec. (f)(2). Pub. L. 117–286 substituted “chapter 10 of title 5” for “FACA” in heading and “chapter 10 of title 5.” for “the Federal Advisory Committee Act (5 U.S.C. App.).” in text.

2021—Subsec. (a)(1)(B)(i). Pub. L. 117–71, § 4(b)(1), substituted “December 31, 2022” for “December 31, 2021”.

Subsec. (a)(1)(B)(ii). Pub. L. 117–71, § 4(b)(2), substituted “January 1, 2023” for “January 1, 2022” and “March 31, 2023” for “March 31, 2022”.

Subsec. (b)(3)(A). Pub. L. 117–71, § 4(a)(1), substituted “through 2025” for “through 2024”.

Subsec. (b)(3)(B)(ii). Pub. L. 117–71, § 4(a)(2)(A), substituted “for each of 2021 and 2022” for “for 2021”.

Subsec. (b)(3)(B)(iii). Pub. L. 117–71, § 4(a)(2)(B), substituted “2023 through 2025” for “2022 through 2024”.

2020—Subsec. (a)(1)(B)(i). Pub. L. 116–136, § 3718(a)(1), substituted “December 31, 2021” for “December 31, 2020”.

Subsec. (a)(1)(B)(ii). Pub. L. 116–136, § 3718(a)(2), substituted “January 1, 2022” for “January 1, 2021” and “March 31, 2022” for “March 31, 2021”.

Subsec. (b)(3)(A). Pub. L. 116–136, § 3718(b)(1), substituted “through 2024” for “through 2023”.

Subsec. (b)(3)(B). Pub. L. 116–136, § 3718(b)(2), added cl. (ii), redesignated former cl. (ii) as (iii), and substituted “2022 through 2024” for “2021 through 2023” in cl. (iii).

2019—Subsec. (a)(1). Pub. L. 116–94, § 105(a)(1)(A), designated existing provisions as subpar. (A) and inserted heading, substituted “Subject to subparagraph (B), beginning January 1, 2016” for “Beginning January 1, 2016”, inserted “(referred to in this subsection as the ‘reporting period’)” after “at a time specified by the Secretary”, and added subpar. (B).

Subsec. (a)(4). Pub. L. 116–94, § 105(a)(1)(B), designated existing provisions as subpar. (A) and inserted heading, substituted “Subject to subparagraph (B), in this section” for “In this section”, and added subpar. (B).

Subsec. (b)(3)(A). Pub. L. 116–94, § 105(a)(2)(A), substituted “through 2023” for “through 2022”.

Subsec. (b)(3)(B)(i). Pub. L. 116–94, § 105(a)(2)(B)(i), substituted “through 2020” for “through 2019”.

Subsec. (b)(3)(B)(ii). Pub. L. 116–94, § 105(a)(2)(B)(ii), substituted “2021 through 2023” for “2020 through 2022”.

Statutory Notes and Related Subsidiaries

Monitoring of Medicare Expenditures and Implementation of New Payment System for Laboratory Tests

Pub. L. 113–93, title II, § 216(c)(2), Apr. 1, 2014, 128 Stat. 1061, provided that: “The Inspector General of the Department of Health and Human Services shall—

“(A)

publicly release an annual analysis of the top 25 laboratory tests by expenditures under title XVIII of the Social Security Act [42 U.S.C. 1395 et seq.]; and

“(B)

conduct analyses the Inspector General determines appropriate with respect to the implementation and effect of the new payment system for laboratory tests under section 1834A of the Social Security Act [42 U.S.C. 1395m–1], as added by subsection (a).”